Revelation Biosciences (REVB) Short Interest Ratio & Short Volume $1.25 -0.02 (-1.19%) As of 03:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Revelation Biosciences Short Interest DataRevelation Biosciences (REVB) has a short interest of 66,800 shares, representing 2.88% of the float (the number of shares available for trading by the public). This marks a -37.69% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 288,753 shares to cover all short positions.Current Short Interest66,800 sharesPrevious Short Interest107,200 sharesChange Vs. Previous Month-37.69%Dollar Volume Sold Short$94.86 thousandShort Interest Ratio0.2 Days to CoverLast Record DateSeptember 30, 2025Outstanding Shares2,340,000 sharesFloat Size2,320,000 sharesShort Percent of Float2.88%Today's Trading Volume65,761 sharesAverage Trading Volume288,753 sharesToday's Volume Vs. Average23% Short Selling Revelation Biosciences? Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartREVB Short Interest Over TimeREVB Days to Cover Over TimeREVB Percentage of Float Shorted Over Time Revelation Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/202566,800 shares $94.86 thousand -37.7%2.9%0.2 $1.42 9/15/2025107,200 shares $167.23 thousand -53.4%4.6%0.2 $1.56 8/31/2025229,800 shares $634.25 thousand -5.7%13.5%0.6 $2.76 8/15/2025243,600 shares $628.49 thousand -8.5%14.3%0.5 $2.58 7/31/2025266,200 shares $662.84 thousand +27.0%17.4%0.6 $2.49 7/15/2025209,600 shares $601.55 thousand +831.6%13.7%0.5 $2.87 6/30/202522,500 shares $50.63 thousand -85.3%3.3%0.1 $2.25 6/15/2025153,000 shares $121.48 thousand +11.0%7.5%0.2 $0.79 5/31/2025137,900 shares $117.61 thousand +229.9%8.4%0.1 $0.85 5/15/202541,800 shares $126.65 thousand -39.9%4.3%0.4 $3.03 Get the Latest News and Ratings for REVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter. 4/30/202569,600 shares $212.28 thousand -41.3%7.2%0.6 $3.05 4/15/2025118,500 shares $361.43 thousand +131.0%13.1%0.8 $3.05 3/31/202551,300 shares $134.92 thousand +118.3%5.7%0.3 $2.63 3/15/202523,500 shares $79.90 thousand -61.9%2.6%0.1 $3.40 2/28/202561,700 shares $215.33 thousand -31.1%6.8%0.3 $3.49 2/15/202589,500 shares $383.06 thousand +41.2%17.1%0.4 $4.28 1/31/202563,400 shares $239.02 thousand +38.1%12.1%0.3 $3.77 1/15/202545,900 shares $359.86 thousand -80.9%0.6%0.2 $7.84 12/31/2024240,400 shares $110.82 thousand +450.1%2.9%0.1 $0.46 12/15/202443,700 shares $15.73 thousand -65.3%0.5%0 $0.36 11/30/2024125,800 shares $95.61 thousand -70.7%2.0%0.1 $0.76 11/15/2024428,600 shares $344.17 thousand +937.8%10.0%0.8 $0.80 10/31/202441,300 shares $35.23 thousand +81.1%1.1%0 $0.85 10/15/202422,800 shares $17.78 thousand -59.7%0.6%0 $0.78 9/30/202456,600 shares $48.21 thousand +120.2%1.5%0 $0.85 9/15/202425,700 shares $23.10 thousand -78.7%0.7%0 $0.90 8/31/2024120,400 shares $138.46 thousand -61.6%7.3%0.1 $1.15 8/15/2024313,700 shares $280.89 thousand +645.1%19.1%0.2 $0.90 7/31/202442,100 shares $69.47 thousand -10.6%2.6%0.1 $1.65 7/15/202447,100 shares $88.08 thousand -44.3%2.9%0.1 $1.87 6/30/202484,500 shares $161.40 thousand +128.4%5.2%0.1 $1.91 6/15/202437,000 shares $81.77 thousand +68.2%2.3%0.1 $2.21 5/31/202422,000 shares $41.14 thousand -11.3%1.4%0.3 $1.87 5/15/202424,800 shares $48.36 thousand +40.1%1.5%0.2 $1.95 4/30/202417,700 shares $37.30 thousand -4.3%1.1%0.1 $2.11 4/15/202418,500 shares $33.76 thousand -43.6%1.1%0 $1.83 3/31/202432,800 shares $89.87 thousand No Change8.3%0.1 $2.74 3/15/202432,800 shares $79.05 thousand -31.5%8.3%0.1 $2.41 2/29/202447,900 shares $174.84 thousand +32.7%12.3%0.1 $3.65 2/15/202436,100 shares $109.02 thousand -70.0%9.2%0.1 $3.02 1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80 1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22 12/31/2023451,700 shares $226.17 thousand +4.7%7.3%6.7 $0.50 12/15/2023431,400 shares $237.70 thousand +1,878.9%7.0%7.2 $0.55 11/30/202321,800 shares $15.76 thousand -29.5%0.4%0.4 $0.72 11/15/202330,900 shares $19.48 thousand +134.1%0.5%0.6 $0.63 10/31/202313,200 shares $7.93 thousand -50.6%0.2%0.2 $0.60 10/15/202326,700 shares $18.21 thousand +69.0%0.4%0.4 $0.68 9/30/202315,800 shares $10.89 thousand +79.6%0.3%0.2 $0.69 9/15/20238,800 shares $6.69 thousand +27.5%0.1%0.1 $0.76 8/31/20236,900 shares $4.64 thousand -11.5%0.1%0.1 $0.67 8/15/20237,800 shares $5.59 thousand +14.7%0.1%0.1 $0.72 7/31/20236,800 shares $5.58 thousand -26.9%0.1%0 $0.82 7/15/20239,300 shares $7.79 thousand -35.9%0.2%0 $0.84 6/30/202314,500 shares $13.74 thousand -74.6%0.3%0 $0.95 6/15/202357,000 shares $63.27 thousand -39.8%1.0%0.1 $1.11 5/31/202394,700 shares $99.44 thousand +38.5%1.6%0.1 $1.05 5/15/202368,400 shares $77.29 thousand -26.8%1.2%0.1 $1.13 4/30/202393,400 shares $100.87 thousand -44.9%2.2%0.1 $1.08 REVB Short Interest - Frequently Asked Questions What is Revelation Biosciences' current short interest? Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 66,800 shares of REVB short. 2.88% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest. What is a good short interest percentage for Revelation Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.88% of Revelation Biosciences' floating shares are currently sold short. Is Revelation Biosciences' short interest increasing or decreasing? Revelation Biosciences saw a decrease in short interest during the month of September. As of September 30th, there was short interest totaling 66,800 shares, a decrease of 37.7% from the previous total of 107,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Revelation Biosciences' float size? Revelation Biosciences currently has issued a total of 2,340,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 2,320,000 shares. How does Revelation Biosciences' short interest compare to its competitors? 2.88% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Revelation Biosciences: Phio Pharmaceuticals Corp. (5.66%), Imunon, Inc. (8.87%), Gelteq Limited (1.08%), TransCode Therapeutics Inc. (5.22%), Acurx Pharmaceuticals, Inc. (4.36%), Mustang Bio, Inc. (0.99%), 180 Life Sciences Corp. (30.55%), CDT Equity Inc. (12.91%), TherapeuticsMD, Inc. (0.34%), Silexion Therapeutics Corp (1.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($15.71 billion), Robinhood Markets, Inc. ($7.56 billion), Reddit Inc. ($4.55 billion), Coinbase Global, Inc. ($4.53 billion), CoreWeave Inc. ($4.43 billion), Charter Communications, Inc. ($4.07 billion), Seagate Technology Holdings PLC ($3.94 billion), IonQ, Inc. ($3.78 billion), TC Energy Corporation ($3.13 billion), and Live Nation Entertainment, Inc. ($3.12 billion). View all of the most shorted stocks. What does it mean to sell short Revelation Biosciences stock? Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revelation Biosciences? A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further. How often is Revelation Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is September, 30 2025. More Short Interest Resources from MarketBeat Related Companies PHIO Short Interest IMNN Short Interest GELS Short Interest RNAZ Short Interest ACXP Short Interest MBIO Short Interest ATNF Short Interest CDT Short Interest TXMD Short Interest SLXN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REVB) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
